Glycaemic control is a modifiable risk factor for pancreatic cancer development in patients with diabetes: a population-based cohort study
Optimal glycaemic control was associated with lower PC risk in T2D. Further multicentre cohort studies are warranted to confirm its oncopreventive strategy.
Authors
- David Tak Wai Lui (ORCID: https://orcid.org/0000-0002-9813-1126)
- Jing Tong Tan (ORCID: https://orcid.org/0000-0002-3973-5376)
- Xianhua Mao
- Wai K. Leung (ORCID: https://orcid.org/0000-0002-5993-1059)
- Ka Shing Cheung (ORCID: https://orcid.org/0000-0002-4838-378X)
- Chang Li (ORCID: https://orcid.org/0000-0003-4681-0191)
- Ho Ming Cheng (ORCID: https://orcid.org/0000-0001-8404-223X)
- Wai‐Kay Seto (ORCID: https://orcid.org/0000-0002-9012-313X)
Institutions
- Chinese University of Hong Kong (HK)
- University of Hong Kong - Shenzhen Hospital (CN)
- University of Hong Kong (HK)
Publication Details
- Journal
- Gut
- Published
- 2025-09-18
- DOI
- https://doi.org/10.1136/gutjnl-2025-335837
- Citations
- 1
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 1.05